EMILOK Global. (omeprazole) Composition: Each capsule contains 20 mg omeprazole as enteric-coated

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "EMILOK Global. (omeprazole) Composition: Each capsule contains 20 mg omeprazole as enteric-coated"

Transcription

1 EMILOK Global (omeprazole) Composition: Each capsule contains 20 mg omeprazole as enteric-coated granules. Properties: Emilok (omeprazole) belongs to the group of proton pump inhibitors, inhibits both basal and stimulated secretion of stomach acid, and reduces the amount of pepsin. This reduction in acidity leading to relief of pain & to accelerate healing of the mucous membrane defect. omeprazole is a weak base and is concentrated and converted to the active form in the acid environment of the intracellular canaliculi within the parietal cell, where it inhibits the enzyme hydrogen-potassium adenosine triphosphatase (H+,K+-ATPase) is the proton pump : omeprazole is acid labile and is administered orally as enteric-coated granules in capsules its absorption takes place in the small intestine and is usually completed within 3-6 hours. Omeprazole is mainly metabolised in the liver through cytochrome P450. Eradication of Helicobacter pylori with omeprazole and antimicrobials is associated with rapid symptom relief, high rates of healing of any mucosal lesions. Indications: Emilok is indicated in the treatment of the following diseases: - Duodenal ulcer. - Gastric ulcer. - Reflux esophagitis.. - Gastritis which results from NSAID treatment. - Used in combination with antibiotics to treat certain types of ulcers. - Prophylaxis of acid aspiration. - Zollinger-Ellison syndrome. Dosage & Administration: Emilok capsules are recommended to be given in the morning before breakfast and swallowed whole with liquid. - Duodenal ulcer: mg once daily before meal for at least 4 weeks depending on the severity of ulcer and persistence of symptoms. - Gastric ulcer: mg once daily before meal for at least 8 weeks depending on the severity of ulcer and persistence of symptoms. - Reflux esophagitis: 20 mg once or twice daily for 8-12 weeks, depending on the severity of the lesion. - Gastritis or hyperacidity: mg once or twice daily for 1-2 weeks. - Helicobacter pylori (Hp) eradication regimens in peptic ulcer disease: Emilok is recommended at a dose of 40 mg once daily or 20 mg twice daily in association with antimicrobial agents as detailed below: Triple therapy regimens in peptic ulcer disease: Emilok and the following antimicrobial combinations: 1- amoxycillin 500 mg and metronidazole 400 mg both three times a day for one week. 2- clarithromycin 250 mg and metronidazole 400 mg (or tinidazole 500 mg) both twice a day for one week. 3- amoxycillin 1 g and clarithromycin 500 mg both twice a day for one week. If symptoms return and the patient is Hp positive, therapy may be repeated, if the patient is Hp negative then see dosage instructions for add reflux disease. - As prophylaxis for patients considered to be at risk of aspiration of the gastric contents during general anaesthesia, the recommended dosage is Emilok 40 mg on the evening before surgery followed by Emilok 40 mg 2-6 hours prior to surgery - Zollinger-Ellison syndrome: the recommended initial dosage is 60 mg Emilok once daily.

2 The dosage should be adjusted individually and treatment continued as long as clinically indicated. If patient administers dose above 80 mg daily, should be divided and given twice daily. Impaired renal function: Dose adjustment is not required in patients with impaired renal function. Impaired hepatic function: As bioavailability and half-life can increase in patients with impaired hepatic function, the dose requires adjustment with a maximum daily dose of 20 mg. Patients with swallowing difficulties: The capsules may be opened and the contents swallowed alone or suspended in a small amount of fruit juice or yogurt after gentle mixing. The dispersion should be taken immediately or within 30 minutes. The contents of the capsules should not be crushed or chewed. Contraindications: Known hypersensitivity to omeprazole. When gastric ulcer is suspected, the possibility of malignancy should be excluded before treatment with Emilok. Precautions: Should be caution, if the drug used for a long period may lead to slightly increased risk of gastrointestinal infections such as Salmonella and Campylobacter. Use in Pregnancy and lactation: Should not be given during pregnancy and lactation unless the physician considers its use is essential. Side effects: Emilok is well tolerated and adverse reactions have generally been mild and reversible, the following effects have been reported: - Central and peripheral nervous system: Headache, rarely Dizziness, Paraesthesia, Insomnia, Reversible mental confusion, Depression and hallucinations. - Gastrointestinal: Diarrhea, Constipation, Abdominal pain, Nausea, Vomiting and Flatulence, Dry mouth, Stomatitis and Gastrointestinal candidiasis. - Hepatic: Rarely increased liver enzymes. - Skin: Rash, Pruritus, Urticaria, Photosensitivity, Erythema multiforme, and Alopecia. - Endocrine: Gynaecomastia. - Haematological: Leukopenia, Thrombocytopenia. - Musculoskeletal: Arthralgia and Myalgia, and Muscular weakness. - Other: Malaise. Drug interactions: - Due to the decreased intragastric acidity the absorption of ketoconazole or itraconazole may be reduced during omeprazole treatment. - Can prolong the elimination of diazepam, phenytoin and warfarin. Monitoring of patients receiving warfarin or phenytoin is recommended and a reduction of warfarin or phenytoin dose may be necessary. - Plasma concentrations of omeprazole and clarithromycin are increased during concomitant administration. This is considered to be a useful interaction during H. pylori eradication. - The absorption of Emilok is not affected by the food. - There is no evidence of an interaction with piroxicam, diclofenac or naproxen. Overdosage: There is no a specific antidote is known for overdosage with Emilok, dosages up to 560 mg/day have been well tolerated. Treatment should be symptomatic and supportive. The clinical symptoms of Emilok overdosage include( Nausea, vomiting, dizziness, abdominal pain, diarrhoea and headache) Presentation: Emilok 20 mg capsules in a container of 14 capsules. Store below 25ºC in a dry place. Protect from light. Keep the container tightly closed. Insert code: LFT 0010 (Org.) April 2005

3

4

5

6

All pharmacodynamic effects observed can be explained by the effect of omeprazole on acid secretion.

All pharmacodynamic effects observed can be explained by the effect of omeprazole on acid secretion. OMEPRAZOLE Losec 10mg and 20mg Capsules Acid Pump Inhibitors FORMULATION Each capsule contains Omeprazole 10 mg or 20 mg. PHARMACEUTICAL FORM Omeprazole (LOSEC) capsule 10 mg: hard gelatin capsule with

More information

Gastric ulcer: The recommended dosage is Pepzol 20 mg once daily. Symptom resolution is rapid and in most

Gastric ulcer: The recommended dosage is Pepzol 20 mg once daily. Symptom resolution is rapid and in most Name Pepzol (Omeprazole) 20 mg, 40 mg Modified release (MR) Capsules Composition Each capsule Contains: Omeprazole 20 mg or 40 mg For excipients see "list of excipients" Pharmaceutical form Pepzol capsules

More information

LOSEC MUPS 10 mg, 20 mg and 40 mg Tablets ASTRAZENECA

LOSEC MUPS 10 mg, 20 mg and 40 mg Tablets ASTRAZENECA 10-14 LOSEC MUPS 10 mg, 20 mg and 40 mg Tablets ASTRAZENECA omeprazole Tablets Composition Each tablet contains: Omeprazole magnesium 10.3 mg, 20.6 mg and 41.3 mg (corresponding to omeprazole 10 mg, 20

More information

0BCore Safety Profile. Pharmaceutical form(s)/strength: Losec MUPS tablets 10, 20 mg (OTC) NL/H/PSUR/0058/001 Date of FAR:

0BCore Safety Profile. Pharmaceutical form(s)/strength: Losec MUPS tablets 10, 20 mg (OTC) NL/H/PSUR/0058/001 Date of FAR: 0BCore Safety Profile Active substance: Omeprazole Pharmaceutical form(s)/strength: Losec MUPS tablets 10, 20 mg (OTC) P-RMS: NL/H/PSUR/0058/001 Date of FAR: 13.06.2013 4.2 Posology and method of administration

More information

* Adults. NSAID associated peptic ulceration: - Acute treatment: 150 mg twice daily for 8 to 12 weeks, or 300mg nocte.

* Adults. NSAID associated peptic ulceration: - Acute treatment: 150 mg twice daily for 8 to 12 weeks, or 300mg nocte. Trade Name Aciloc 75 mg & 300 mg Film-coated tablets Generic Name Ranitidine Composition Each Aciloc 300 mg film-coated tablet contains: - Active ingredient: Ranitidine hydrochloride 336 mg equivalent

More information

0BCore Safety Profile. Pharmaceutical form(s)/strength: Gastro-resistant capsules (10, 20, 40 mg) NL/H/PSUR/0058/001 Date of FAR:

0BCore Safety Profile. Pharmaceutical form(s)/strength: Gastro-resistant capsules (10, 20, 40 mg) NL/H/PSUR/0058/001 Date of FAR: 0BCore Safety Profile Active substance: Omeprazole Pharmaceutical form(s)/strength: Gastro-resistant capsules (10, 20, 40 mg) P-RMS: NL/H/PSUR/0058/001 Date of FAR: 10.04.2013 CSP Drug Substance Omeprazole

More information

OMEPREX 20 mg Capsules SAJA PHARMA

OMEPREX 20 mg Capsules SAJA PHARMA 08-15 OMEPREX 20 mg Capsules SAJA PHARMA Omeprazole 1. NAME OF THE MEDICINAL PRODUCT Omeprex 20 mg 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 20 mg omeprazole. Excipient: For a full

More information

PROPOSED PACKAGE INSERT FOR PRAZOLOC 20 / 40

PROPOSED PACKAGE INSERT FOR PRAZOLOC 20 / 40 PROPOSED PACKAGE INSERT FOR PRAZOLOC 20 / 40 SCHEDULING STATUS: S4 PROPRIETARY NAME (AND DOSAGE FORM): PRAZOLOC 20 (Enteric-coated tablets) PRAZOLOC 40 (Enteric-coated tablets) COMPOSITION: PRAZOLOC 20:

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Omeprazol XXX 40 mg, powder for solution for infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each vial of powder for solution for

More information

ANNEX III SUMMARY OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET

ANNEX III SUMMARY OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET ANNEX III SUMMARY OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET Note: This SPC, labelling and package leaflet is the version valid at the time of Commission Decision. After the Commission Decision

More information

OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF LOSEC AND ASSOCIATED NAMES (SEE ANNEX I)

OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF LOSEC AND ASSOCIATED NAMES (SEE ANNEX I) ANNEX II SCIENTIFIC CONCLUSIONS AND GROUNDS FOR AMENDMENT OF THE SUMMARY OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET PRESENTED BY THE EMEA 21 SCIENTIFIC CONCLUSIONS OVERALL SUMMARY OF THE

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each hard gelatin capsule contains 20mg of omeprazole For the full list of excipients, see

More information

Maxor Heartburn Relief Omeprazole

Maxor Heartburn Relief Omeprazole Maxor Heartburn Relief Omeprazole PRODUCT INFORMATION Name of the Medicine Active ingredient: Omeprazole Chemical Name: 5-methoxy-2-[(RS) -[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-sulfinyl]-1H-benzimidazole.

More information

APO-OMEPRAZOLE CAPSULES. (RS)-5-methoxy-2-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1Hbenzimidazole. Omeprazole

APO-OMEPRAZOLE CAPSULES. (RS)-5-methoxy-2-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1Hbenzimidazole. Omeprazole APO-OMEPRAZOLE CAPSULES NAME OF MEDICINE Active Ingredient: Chemical Name: Omeprazole (RS)-5-methoxy-2-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1Hbenzimidazole Omeprazole Molecular Formula:

More information

2. QUALITATIVE AND QUANTITATIVE COMPOSITION. One vial contains 40 mg pantoprazole (as pantoprazole sodium sesquihydrate).

2. QUALITATIVE AND QUANTITATIVE COMPOSITION. One vial contains 40 mg pantoprazole (as pantoprazole sodium sesquihydrate). a Novartis Company 1. NAME OF THE MEDICINAL PRODUCT 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One vial contains 40 mg pantoprazole (as pantoprazole sodium sesquihydrate). 3. PHARMACEUTICAL FORM Powder

More information

New Zealand Data Sheet Pantoprazole Actavis

New Zealand Data Sheet Pantoprazole Actavis New Zealand Data Sheet Pantoprazole Actavis Pantoprazole Sodium Sesquihydrate, enteric coated tablets, 20 mg and 40 mg (as pantoprazole) Presentation 20 mg: Light yellow, elliptical, gastro-resistant film

More information

SUMMARY OF PRODUCT CHARACTERISTICS 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

SUMMARY OF PRODUCT CHARACTERISTICS 2 QUALITATIVE AND QUANTITATIVE COMPOSITION SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Omeprazole 20mg gastro-resistant capsules, hard 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Omeprazole 20 mg capsules: one capsule contains

More information

Product Information Omeprazole Winthrop 20mg Enteric-Coated Tablets 10/2012 PRODUCT INFORMATION

Product Information Omeprazole Winthrop 20mg Enteric-Coated Tablets 10/2012 PRODUCT INFORMATION PRODUCT INFORMATION 1 OMEPRAZOLE WINTHROP 20MG ENTERIC-COATED TABLETS NAME OF THE MEDICINE Chemical name: 5-methoxy-2-[(RS)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]- sulphinyl]-1h-benzimidazole Generic

More information

Copy right protected Page 1

Copy right protected Page 1 DRUGS USED IN ULCERS AND GIT DISORDERS A peptic ulcer, also known as PUD or peptic ulcer disease is an ulcer of an area of the gastrointestinal tract that is usually acidic and thus extremely painful.

More information

PRODUCT INFORMATION AUSRAN. (150 mg and 300 mg TABLETS)

PRODUCT INFORMATION AUSRAN. (150 mg and 300 mg TABLETS) PRODUCT INFORMATION AUSRAN (150 mg and 300 mg TABLETS) NAME OF MEDICINES AUSRAN tablets contain ranitidine hydrochloride. Its chemical structure is represented below: CAS No.: 66357-59-3 Empirical Formula:

More information

Package leaflet: Information for the user. Omeprazol STADA 20 mg gastro-resistant tablets Omeprazole

Package leaflet: Information for the user. Omeprazol STADA 20 mg gastro-resistant tablets Omeprazole Package leaflet: Information for the user Omeprazol STADA 20 mg gastro-resistant tablets Omeprazole Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

Product Information Page 1 Omeprazole Sandoz IV 40 mg powder for injection 11/2017

Product Information Page 1 Omeprazole Sandoz IV 40 mg powder for injection 11/2017 Product Information Page 1 PRODUCT INFORMATION OMEPRAZOLE SANDOZ IV 40 mg POWDER FOR INJECTION NAME OF THE MEDICINE Generic name: Omeprazole sodium Chemical name: sodium 5-methoxy-2-[(RS)-[(4-methoxy-3,5-dimethylpyridin-2-

More information

Omeprazole generichealth Enteric-coated Tablets

Omeprazole generichealth Enteric-coated Tablets Enteric-coated Tablets contain the active ingredient omeprazole CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about. It does not contain all of the available

More information

PRODUCT MONOGRAPH. esomeprazole delayed release tablets. 20 and 40 mg esomeprazole (as esomeprazole magnesium trihydrate)

PRODUCT MONOGRAPH. esomeprazole delayed release tablets. 20 and 40 mg esomeprazole (as esomeprazole magnesium trihydrate) PRODUCT MONOGRAPH Pr NEIUM esomeprazole delayed release tablets 20 and 40 mg esomeprazole (as esomeprazole magnesium trihydrate) esomeprazole delayed release granules for oral suspension (sachet) 10 mg

More information

EU RISK MANAGEMENT PLAN (EU RMP)

EU RISK MANAGEMENT PLAN (EU RMP) EU RISK MANAGEMENT PLAN (EU RMP) Active substance(s) (INN or common name): Esomeprazole Pharmaco-therapeutic group (ATC Code): A02B C05 Name of Marketing Authorisation Holder or Applicant: Strength and

More information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION - 1 - READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION LOSEC Omeprazole delayed release tablets, 10, 20 mg (as omeprazole magnesium) Read this carefully before you start

More information

[Al(OH) 3. ] x [H 2. O]y

[Al(OH) 3. ] x [H 2. O]y CARAFATE Tablets (sucralfate) DESCRIPTIN CARAFATE Tablets contain sucralfate and sucralfate is an α-d-glucopyranoside, β-dfructofuranosyl-, octakis-(hydrogen sulfate), aluminum complex. R [Al(H) 3 ] x

More information

MANAGEMENT OF DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)

MANAGEMENT OF DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) Routine endoscopic investigation of patients of any age, presenting with dyspepsia

More information

GASTROINTESTINAL SYSTEM MANAGEMENT OF DYSPEPSIA

GASTROINTESTINAL SYSTEM MANAGEMENT OF DYSPEPSIA GASTROINTESTINAL SYSTEM MANAGEMENT OF DYSPEPSIA MANAGEMENT Dyspepsia refers to a spectrum of usually intermittent upper gastrointestinal symptoms, including epigastric pain and heartburn. For the majority

More information

Losamel 20mg Gastro-resistant Tablets

Losamel 20mg Gastro-resistant Tablets Package leaflet: Information for the user Losamel 20mg Gastro-resistant Tablets Omeprazole Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

Pharmaceutical form(s)/strength: Capsules, 200mg, 400mg, Oral suspensions, 90mg/5ml, 180mg/5ml, 36 mg/ml SI/H/PSUR/0002/002 Date of FAR:

Pharmaceutical form(s)/strength: Capsules, 200mg, 400mg, Oral suspensions, 90mg/5ml, 180mg/5ml, 36 mg/ml SI/H/PSUR/0002/002 Date of FAR: 0BCore Safety Profile Active substance: Ceftibuten Pharmaceutical form(s)/strength: Capsules, 200mg, 400mg, Oral suspensions, 90mg/5ml, 180mg/5ml, 36 mg/ml P-RMS: SI/H/PSUR/0002/002 Date of FAR: 14.02.2013

More information

[Al(OH) 3. ] x [H 2. O]y

[Al(OH) 3. ] x [H 2. O]y CARAFATE (sucralfate) ral Suspension DESCRIPTIN CARAFATE ral Suspension contains sucralfate and sucralfate is an α-d-glucopyranoside, β-dfructofuranosyl-, octakis-(hydrogen sulfate), aluminum complex.

More information

omeprazole magnesium Multiple Unit Pellet System PRODUCT INFORMATION

omeprazole magnesium Multiple Unit Pellet System PRODUCT INFORMATION ACIMAX TABLETS omeprazole magnesium Multiple Unit Pellet System PRODUCT INFORMATION NAME OF THE MEDICINE ACIMAX is a proton pump inhibitor. The active ingredient in ACIMAX Tablets is omeprazole magnesium,

More information

CHAPTER 18. PEPTIC ULCER DISEASE, SELF-ASSESSMENT QUESTIONS. 1. Which of the following is not a common cause of peptic ulcer disease (PUD)?

CHAPTER 18. PEPTIC ULCER DISEASE, SELF-ASSESSMENT QUESTIONS. 1. Which of the following is not a common cause of peptic ulcer disease (PUD)? CHAPTER 18. PEPTIC ULCER DISEASE, SELF-ASSESSMENT QUESTIONS 1. Which of the following is not a common cause of peptic ulcer disease (PUD)? A. Chronic alcohol ingestion B. Nonsteroidal antiinflammatory

More information

TILAZEM. Diltiazem hydrochloride 240 mg

TILAZEM. Diltiazem hydrochloride 240 mg Tilazem Capsules Page 1 of 9 TILAZEM Diltiazem hydrochloride SCHEDULING STATUS: S3 PROPRIETARY NAME (AND DOSAGE FORM): TILAZEM 180 CR (controlled-release capsule) TILAZEM 240 CR (controlled-release capsule)

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. ULCERBREX 10 mg mg gastro-resistant tablets Rabeprazole sodium

PACKAGE LEAFLET: INFORMATION FOR THE USER. ULCERBREX 10 mg mg gastro-resistant tablets Rabeprazole sodium PACKAGE LEAFLET: INFORMATION FOR THE USER ULCERBREX 10 mg mg gastro-resistant tablets Rabeprazole sodium Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

NEXIUM IV (INTRAVENOUS INJECTION AND INTRAVENOUS INFUSION)

NEXIUM IV (INTRAVENOUS INJECTION AND INTRAVENOUS INFUSION) NEXIUM IV (INTRAVENOUS INJECTION AND INTRAVENOUS INFUSION) esomeprazole sodium PRODUCT INFORMATION NAME OF THE MEDICINE NEXIUM is a proton pump inhibitor. The active ingredient in NEXIUM IV is esomeprazole

More information

Cetirizine Proposed Core Safety Profile

Cetirizine Proposed Core Safety Profile Cetirizine Proposed Core Safety Profile Posology and method of administration Elderly subjects: data do not suggest that the dose needs to be reduced in elderly subjects provided that the renal function

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Losec 10 mg hard capsules Losec 20 mg hard capsules Losec 40 mg hard capsules Omeprazole

PACKAGE LEAFLET: INFORMATION FOR THE USER. Losec 10 mg hard capsules Losec 20 mg hard capsules Losec 40 mg hard capsules Omeprazole PACKAGE LEAFLET: INFORMATION FOR THE USER Losec 10 mg hard capsules Losec 20 mg hard capsules Losec 40 mg hard capsules Omeprazole Read all of this leaflet carefully before you start taking this medicine.

More information

Diarrhea. Omeprazole and Sodium Bicarbonate may increase your risk of getting severe diarrhea. This

Diarrhea. Omeprazole and Sodium Bicarbonate may increase your risk of getting severe diarrhea. This Medication Guide Omeprazole and Sodium Bicarbonate Powder for Oral Suspension and Capsules Read this Medication Guide before you start taking Omeprazole and Sodium Bicarbonate and each time you get a refill.

More information

Drug Class Monograph

Drug Class Monograph Drug Class Monograph Class: Proton Pump Inhibitors Drugs: Aciphex Sprinkle (rabeprazole), Dexilant (dexlansoprazole), Lansoprazole, Nexium (esomeprazole capsule, esomeprazole granules), Omeprazole, Pantoprazole,

More information

Summary of Product Characteristics

Summary of Product Characteristics Summary of Product Characteristics 1. NAME OF THE MEDICINAL PRODUCT Cimeldine 200 mg and 400 mg Film-coated Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Cimeldine 200 mg Tablets Each tablet contains

More information

Immodium / loprarmide

Immodium / loprarmide Immodium / loprarmide IMODIUM (loperamide hydrochloride) is indicated for the control and symptomatic relief of acute nonspecific diarrhea and of chronic diarrhea associated with inflammatory bowel disease.

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Omeprazole Pinewood 20 mg Gastro-resistant capsules, hard Omeprazole

PACKAGE LEAFLET: INFORMATION FOR THE USER. Omeprazole Pinewood 20 mg Gastro-resistant capsules, hard Omeprazole PACKAGE LEAFLET: INFORMATION FOR THE USER Omeprazole Pinewood 20 mg Gastro-resistant capsules, hard Omeprazole Read all of this leaflet carefully before you start taking this medicine because it contains

More information

PRODUCT MONOGRAPH. Pr NEXIUM. esomeprazole delayed release tablets. 20 and 40 mg esomeprazole (as esomeprazole magnesium trihydrate)

PRODUCT MONOGRAPH. Pr NEXIUM. esomeprazole delayed release tablets. 20 and 40 mg esomeprazole (as esomeprazole magnesium trihydrate) PRODUCT MONOGRAPH Pr NEXIUM esomeprazole delayed release tablets 20 and 40 mg esomeprazole (as esomeprazole magnesium trihydrate) esomeprazole delayed release granules for oral suspension (sachet) 10 mg

More information

PACKAGE LEAFLET Page 1 of 7

PACKAGE LEAFLET Page 1 of 7 PACKAGE LEAFLET Page 1 of 7 Package leaflet: Information for the user Lansoprazole 15 mg and 30 mg Gastro-resistant Capsules (lansoprazole) Read all of this leaflet carefully before you start taking this

More information

TEVA-OMEPRAZOLE (omeprazole magnesium delayed release tablets)

TEVA-OMEPRAZOLE (omeprazole magnesium delayed release tablets) PRODUCT MONOGRAPH Pr TEVA-OMEPRAZOLE (omeprazole magnesium delayed release tablets) Teva Standard 10 mg Omeprazole as Omeprazole Magnesium 20 mg Omeprazole as Omeprazole Magnesium H +, K + - ATPase Inhibitor

More information

PRODUCT MONOGRAPH AURO-OMEPRAZOLE

PRODUCT MONOGRAPH AURO-OMEPRAZOLE PRODUCT MONOGRAPH Pr AURO-OMEPRAZOLE Omeprazole Delayed Release Capsules 10 and 20 mg omeprazole Manufacturer s Standard H +, K + -ATPase Inhibitor Auro Pharma Inc. 3700 Steeles Avenue West, Suite # 402

More information

METRONIDAZOLE. General Monograph, Antibacterial - Antiprotozoal

METRONIDAZOLE. General Monograph, Antibacterial - Antiprotozoal METRONIDAZOLE General Monograph, Antibacterial - Antiprotozoal Pharmacology: Metronidazole is amebicidal, trichomonacidal and bactericidal. A chemically reactive, reduced form of metronidazole is thought

More information

DATA SHEET. 1. CREON 10,000 Capsules CREON 25,000 Capsules 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 3. PHARMACEUTICAL FORM 4. CLINICAL PARTICULARS

DATA SHEET. 1. CREON 10,000 Capsules CREON 25,000 Capsules 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 3. PHARMACEUTICAL FORM 4. CLINICAL PARTICULARS 1. CREON 10,000 Capsules CREON 25,000 Capsules DATA SHEET 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Pancreatin, produced from porcine pancreatic tissue For a full list of excipients, see Section 6.1

More information

Vemurafenib (Zelboraf ) BRAF V600 mutation positive Metastatic Melanoma

Vemurafenib (Zelboraf ) BRAF V600 mutation positive Metastatic Melanoma Vemurafenib (Zelboraf ) BRAF V600 mutation positive Metastatic Melanoma Background: Vemurafenib has been approved by NICE for the treatment of BRAF V600 mutation positive unresectable or metastatic melanoma.

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER LANSOPRAZOLE 15MG & 30MG GASTRO-RESISTANT CAPSULES

PACKAGE LEAFLET: INFORMATION FOR THE USER LANSOPRAZOLE 15MG & 30MG GASTRO-RESISTANT CAPSULES PACKAGE LEAFLET: INFORMATION FOR THE USER LANSOPRAZOLE 15MG & 30MG GASTRO-RESISTANT CAPSULES Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

PACKAGE LEAFLET INFORMATION FOR THE USER. Cimetidine 200mg Tablets Cimetidine 400mg Tablets Cimetidine 800mg Tablets (Cimetidine)

PACKAGE LEAFLET INFORMATION FOR THE USER. Cimetidine 200mg Tablets Cimetidine 400mg Tablets Cimetidine 800mg Tablets (Cimetidine) PACKAGE LEAFLET INFORMATION FOR THE USER Cimetidine 200mg Tablets Cimetidine 400mg Tablets Cimetidine 800mg Tablets (Cimetidine) Read all of this leaflet carefully before you start taking this medicine.

More information

Package leaflet: Information for the patient. Clarithromycin Kern Pharma 500 film-coated tablets Clarithromycin

Package leaflet: Information for the patient. Clarithromycin Kern Pharma 500 film-coated tablets Clarithromycin Package leaflet: Information for the patient Clarithromycin Kern Pharma 500 film-coated tablets Clarithromycin Read all of this leaflet carefully before you start taking this medicine because it contains

More information

Package leaflet: Information for the patient

Package leaflet: Information for the patient Package leaflet: Information for the patient Esomeprazole Krka 20 mg gastro-resistant capsules, hard Esomeprazole Krka 40 mg gastro-resistant capsules, hard Esomeprazole Read all of this leaflet carefully

More information

CABAZITAXEL Prostate Cancer

CABAZITAXEL Prostate Cancer Systemic Anti-Cancer Treatment Protocol CABAZITAXEL Prostate Cancer PROCTOCOL REF: MPHACABAZ (Version No: 1.0) Approved for use in: Cabazitaxel in combination with prednisolone is a treatment option for

More information

Carboplatin / Liposomal Doxorubicin CARBO/CAELYX Gynaecological Cancer

Carboplatin / Liposomal Doxorubicin CARBO/CAELYX Gynaecological Cancer Systemic Anti Cancer Treatment Protocol Carboplatin / CARBO/CAELYX Gynaecological Cancer PROCTOCOL REF: MPHAGYNCCX (Version No: 1.0) Approved for use in: Advanced ovarian cancer in women who have progressed

More information

Package leaflet: Information for the user. Ranitidine Sandoz effervescent 150, 150 mg effervescent tablets Ranitidine

Package leaflet: Information for the user. Ranitidine Sandoz effervescent 150, 150 mg effervescent tablets Ranitidine Sandoz Business use only Page 1 of 9 PACKAGE LEAFLET Package leaflet: Information for the user Ranitidine Sandoz effervescent 150, 150 mg effervescent tablets Ranitidine Read all of this leaflet carefully

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER PACKAGE LEAFLET: INFORMATION FOR THE USER Lopraz 10 mg Gastro-resistant Capsules Lopraz 20mg Gastro-resistant Capsules Lopraz 40mg Gastro-resistant Capsules Omeprazole Read all of this leaflet carefully

More information

Package leaflet: Information for the patient

Package leaflet: Information for the patient Package leaflet: Information for the patient Losec MUPS 10 mg gastro-resistant tablets Losec MUPS 20 mg gastro-resistant tablets Losec MUPS 40 mg gastro-resistant tablets omeprazole Read all of this leaflet

More information

In another study, a 300 mg dose of cimetidine given with the meal increased gastric ph as compared with placebo.

In another study, a 300 mg dose of cimetidine given with the meal increased gastric ph as compared with placebo. CIMETIDINE - cimetidine tablet, film coated STAT RX USA LLC DESCRIPTION Cimetidine is a histamine H 2 -receptor antagonist. Chemically it is N"-cyano-N-methyl-N'-[2-[[(5-methyl-1H-imidazol-4- yl)methyl]thio]-ethyl]-guanidine.

More information

PRODUCT INFORMATION CREON MICRO ENTERIC-COATED GRANULES NAME OF THE MEDICINE DESCRIPTION PHARMACOLOGY CLINICAL TRIALS

PRODUCT INFORMATION CREON MICRO ENTERIC-COATED GRANULES NAME OF THE MEDICINE DESCRIPTION PHARMACOLOGY CLINICAL TRIALS NAME OF THE MEDICINE Non-proprietary Name Pancreatic Extract PRODUCT INFORMATION CREON MICRO ENTERIC-COATED GRANULES DESCRIPTION Creon Micro are porcine pancreatic enzyme preparations containing Pancreatic

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Melfen 200 mg Film-coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 200 mg ibuprofen. Excipients:

More information

NEW ZEALAND DATA SHEET ACUPAN TM. 3. PHARMACEUTICAL FORM White, round, biconvex, film-coated tablets (7 mm diameter) engraved APN on one face.

NEW ZEALAND DATA SHEET ACUPAN TM. 3. PHARMACEUTICAL FORM White, round, biconvex, film-coated tablets (7 mm diameter) engraved APN on one face. 1. PRODUCT NAME ACUPAN 30 mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains nefopam hydrochloride 30 mg. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM

More information

TAGAMET PRODUCT INFORMATION (cimetidine) N S N H H H 3 C N. Cimetidine is an odourless white to off-white powder, slightly soluble in water.

TAGAMET PRODUCT INFORMATION (cimetidine) N S N H H H 3 C N. Cimetidine is an odourless white to off-white powder, slightly soluble in water. TAGAMET PRODUCT INFORMATION (cimetidine) DESCRIPTION TAGAMET (cimetidine) is a histamine H 2 -receptor antagonist. Chemically it is: 2-cyano-1-methyl- 3-{2-(5-methylimidazol-4-yl-methylthio)ethyl} guanidine.

More information

CIMETIDINE TABLETS USP 200 mg, 300 mg, 400 mg and 800 mg DESCRIPTION

CIMETIDINE TABLETS USP 200 mg, 300 mg, 400 mg and 800 mg DESCRIPTION CIMETIDINE TABLETS USP 200 mg, 300 mg, 400 mg and 800 mg Rx Only DESCRIPTION Cimetidine is a histamine H 2 -receptor antagonist. Chemically it is N -cyano-n-methyl-n -[2-[[(5- methyl-1h-imidazol-4-yl)methyl]thio]-ethyl],

More information

FEC-T (Fluorouracil, Epirubicin and Cyclophosphamide and Docetaxel)

FEC-T (Fluorouracil, Epirubicin and Cyclophosphamide and Docetaxel) FEC-T (Fluorouracil, Epirubicin and Cyclophosphamide and Docetaxel) Indication Adjuvant or neo-adjuvant treatment for high risk early and locally advanced breast cancer. (NICE CG80) ICD-10 codes Codes

More information

NEW ZEALAND CONSUMER MEDICINE INFORMATION. OMEZOL RELIEF is also used to help stop reflux oesophagitis coming back or relapsing.

NEW ZEALAND CONSUMER MEDICINE INFORMATION. OMEZOL RELIEF is also used to help stop reflux oesophagitis coming back or relapsing. NEW ZEALAND CONSUMER MEDICINE INFORMATION Omeprazole modified release capsules 10 mg, 20 mg and 40 mg What is in this leaflet This leaflet answers some of the common questions about OMEZOL It does not

More information

SANDOMIGRAN (pizotifen malate)

SANDOMIGRAN (pizotifen malate) SANDOMIGRAN (pizotifen malate) S N CH 3 Pizotifen. COOH CH OH CH 2 COOH MALATE DESCRIPTION Pizotifen is a cycloheptathiophene derivative structurally related to cyproheptadine and the tricyclic antidepressants.

More information

Public Assessment Report. Decentralised Procedure

Public Assessment Report. Decentralised Procedure Public Assessment Report Decentralised Procedure Pantoprazole 20mg Gastro-Resistant Tablets Pantoprazole 40mg Gastro-Resistant Tablets UK licence nos: PL 04569/0848-51 Generics (UK) Limited 1 LAY SUMMARY

More information

APO-Omeprazole Contains the active ingredient omeprazole Consumer Medicine Information

APO-Omeprazole Contains the active ingredient omeprazole Consumer Medicine Information APO-Omeprazole Contains the active ingredient omeprazole Consumer Medicine Information For a copy of a large print leaflet, Ph: 1800 195 055 What is in this leaflet Read this leaflet carefully before taking

More information

SPC. Each tablet contains 70 mg alendronic acid (as sodium alendronate trihydrate). Each tablet contains about 192 mg lactose monohydrate.

SPC. Each tablet contains 70 mg alendronic acid (as sodium alendronate trihydrate). Each tablet contains about 192 mg lactose monohydrate. SPC 1. NAME OF THE MEDICINAL PRODUCT Alendronic acid Actavis 70 mg, tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 70 mg alendronic acid (as sodium alendronate trihydrate). Each

More information

PRODUCT INFORMATION. Creon 10,000 Creon 25,000 Creon 40,000 10,000 25,000 40,000 8,000 18,000 25, ,000 1,600

PRODUCT INFORMATION. Creon 10,000 Creon 25,000 Creon 40,000 10,000 25,000 40,000 8,000 18,000 25, ,000 1,600 NAME OF THE MEDICINE Non-proprietary Name Pancreatic Extract PRODUCT INFORMATION CREON 10,000, CREON 25,000, CREON 40,000, DESCRIPTION Creon 10,000, 25,000 and 40,000 are porcine pancreatic enzyme preparations

More information

Breast Pathway Group EC x 4 Docetaxel x 4: Epirubicin & Cyclophosphamide followed by Docetaxel in Early Breast Cancer

Breast Pathway Group EC x 4 Docetaxel x 4: Epirubicin & Cyclophosphamide followed by Docetaxel in Early Breast Cancer Breast Pathway Group EC x 4 Docetaxel x 4: Epirubicin & Cyclophosphamide followed by Docetaxel in Early Breast Indication: Neoadjuvant therapy for high risk and fit breast cancer patients suitable for

More information

Glucophage XR is contra-indicated during breast-feeding.

Glucophage XR is contra-indicated during breast-feeding. Name GLUCOPHAGE XR 1000 mg Prolonged release tablets Active ingredient Metformin hydrochloride Composition Each Glucophage XR 1000 mg prolonged release tablet contains as active ingredient 1000 mg metformin

More information

FIS 2013, Birmingham

FIS 2013, Birmingham Fidaxomicin: CDDFT Case Studies Dr Deepa Nayar County Durham and Darlington Foundation Trust FIS 2013, Birmingham This meeting has been initiated and funded by Astellas Pharma Ltd. County Durham and Darlington

More information

PRESCRIBING INFORMATION K-10. (Potassium Chloride Oral Solution, 10% USP) POTASSIUM REPLACEMENT THERAPY

PRESCRIBING INFORMATION K-10. (Potassium Chloride Oral Solution, 10% USP) POTASSIUM REPLACEMENT THERAPY PRESCRIBING INFORMATION K-10 (Potassium Chloride Oral Solution, 10% USP) POTASSIUM REPLACEMENT THERAPY GlaxoSmithKline Inc Date of Revision: 7333 Mississauga Road North Aug 30, 2017 Mississauga, Ontario

More information

MOVICOL HALF PI December MOVICOL-Half. Powder for Solution (macrogol 3350) Potassium 5.4 mmol/l. Bicarbonate 17 mmol/l

MOVICOL HALF PI December MOVICOL-Half. Powder for Solution (macrogol 3350) Potassium 5.4 mmol/l. Bicarbonate 17 mmol/l MOVICOL -Half Powder for Solution (macrogol 3350) Product Name: Product Description: MOVICOL-Half Each sachet of MOVICOL-Half contains: Macrogol 3350 6.563 g Sodium chloride 175.4 mg Sodium bicarbonate

More information

Peptic ulcer disease 1 GIT. Dr Kawa Ahmad PhD Pharmaceutics

Peptic ulcer disease 1 GIT. Dr Kawa Ahmad PhD Pharmaceutics 51 Peptic ulcer disease Dr Kawa Ahmad PhD Pharmaceutics 1 GIT Food taken into the mouth is mixed with saliva to form a plastic mass. The salivary glands secrete about 1 L of fluid daily; this contains

More information

HIGHLIGHTS OF PRESCRIBING INFORMATION

HIGHLIGHTS OF PRESCRIBING INFORMATION US-16355 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NEXIUM safely and effectively. See full prescribing information for NEXIUM. NEXIUM (esomeprazole

More information

MOVICOL Junior Powder for Solution (macrogol 3350)

MOVICOL Junior Powder for Solution (macrogol 3350) MOVICOL Junior Powder for Solution (macrogol 3350) Product Name: MOVICOL Junior Product Description: Each sachet of MOVICOL Junior contains: Macrogol 3350 Sodium chloride Sodium bicarbonate Potassium chloride

More information

Helicobacter Pylori Testing HELICOBACTER PYLORI TESTING HS-131. Policy Number: HS-131. Original Effective Date: 9/17/2009

Helicobacter Pylori Testing HELICOBACTER PYLORI TESTING HS-131. Policy Number: HS-131. Original Effective Date: 9/17/2009 Easy Choice Health Plan, Inc. Harmony Health Plan of Illinois, Inc. Missouri Care, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance of Arizona, Inc. WellCare Health Insurance of Illinois,

More information

Pharmaceutical form(s)/strength: Solution: 5 mg/ml Suspensions: 2.5 and 5 mg/ml P-RMS:

Pharmaceutical form(s)/strength: Solution: 5 mg/ml Suspensions: 2.5 and 5 mg/ml P-RMS: 0BCore Safety Profile Active substance: Betaxolol eyedrops Pharmaceutical form(s)/strength: Solution: 5 mg/ml Suspensions: 2.5 and 5 mg/ml P-RMS: HU/H/PSUR/0010/002 Date of FAR: 20.03.2013 4.2 Posology

More information

For more information, call AstraZeneca Access 360 at ASK-A360, Monday through Friday, 8:00 AM to 8:00 PM ET.

For more information, call AstraZeneca Access 360 at ASK-A360, Monday through Friday, 8:00 AM to 8:00 PM ET. 1-844-ASK-A360 1-844-275-2360 1-844-FAX-A360 1-844-329-2360 www.myaccess360.com For more information, call AstraZeneca Access 360 at 1-844-ASK-A360, Monday through Friday, 8:00 AM to 8:00 PM ET. Indications

More information

Operational Guide for School Oral Health Program. Prescribing Medicine

Operational Guide for School Oral Health Program. Prescribing Medicine Prescribing Clinical Protocols Medicine Operational Guide for School Oral Health Program Prescribing Medicine 107 Prescribing Medicine 43, 44, 45 The Kuwait drug index is the only authoritative source

More information

Breast Pathway Group TC (Docetaxel / Cyclophosphamide) in Early Breast Cancer

Breast Pathway Group TC (Docetaxel / Cyclophosphamide) in Early Breast Cancer Breast Pathway Group TC (Docetaxel / Cyclophosphamide) in Early Breast Cancer Indication: Neoadjuvant or adjuvant treatment for patients in whom anthracyclines are contraindicated or inappropriate Regimen

More information

PRESCRIBING SUPPORT TEAM AUDIT: PROTON PUMP INHIBITOR PRESCRIBING REVIEW

PRESCRIBING SUPPORT TEAM AUDIT: PROTON PUMP INHIBITOR PRESCRIBING REVIEW PRESCRIBING SUPPORT TEAM AUDIT: PROTON PUMP INHIBITOR PRESCRIBING REVIEW DATE OF AUTHORISATION: AUTHORISING GP: PRESCRIBING SUPPORT TECHNICIAN: SUMMARY Dyspepsia refers to a broad range of symptoms related

More information

patient group direction

patient group direction NAPROXEN v01 1/10 NAPROXEN PGD Details Version 1.0 Legal category Staff grades Approved by POM Paramedic (Non-ECP) Nurse (Non-ECP) Emergency Care Practitioner (Paramedic) Emergency Care Practitioner (Nurse)

More information

A SLP s Guide to Medication Therapy and Management. Sarah Luby, PharmD, BCPS KSHA 2017

A SLP s Guide to Medication Therapy and Management. Sarah Luby, PharmD, BCPS KSHA 2017 A SLP s Guide to Medication Therapy and Management Sarah Luby, PharmD, BCPS KSHA 2017 Objectives Identify the appropriate route of administration for medications and proper formulations for use Understand

More information

DESCRIPTION: Each tablet for oral administration contains:

DESCRIPTION: Each tablet for oral administration contains: HYOSCYAMINE SULFATE 0.125 MG TABLETS Rx Only 1 2 3 4 DESCRIPTION: Each tablet for oral administration contains: I-Hyoscyamine sulfate... 0.125 mg Inactive ingredients include: green dye, lactose monohydrate,

More information

SIFROL Composition Properties Indication

SIFROL Composition Properties Indication SIFROL Boehringer Composition 1 tablet contains: 0.125, 0.25 or 1.0 mg, (S)-2- amino-4,5,6,7-tetrahydro-6-propylamino-benzothiazole dihydrochloride monohydrate equivalent to 0.088, 0.18 or 0.7 mg pramipexole

More information

NHS Kent and Medway Medicines Management. Dronedarone (Multaq ) Shared Care Guideline For Prescribing

NHS Kent and Medway Medicines Management. Dronedarone (Multaq ) Shared Care Guideline For Prescribing NHS Kent and Medway Medicines Management Dronedarone (Multaq ) Shared Care Guideline For Prescribing Issue No: 2 Review Date (If Applicable): Accountable Officer: Heather Lucas Contact Details: 01233 618158

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen PACKAGE LEAFLET: INFORMATION FOR THE USER EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS Ibuprofen Read all of this leaflet carefully before you start taking Easofen Max Strength Tablets because it contains

More information

Metformin Hydrochloride

Metformin Hydrochloride Metformin Hydrochloride 500 mg, 850 mg, 500 mg LA and 750 mg LA Tablet Description Informet is a preparation of metformin hydrochloride that belongs to a biguanide class of oral antidiabetic drugs. Metformin

More information

What Is Peptic Ulcer Disease?

What Is Peptic Ulcer Disease? What Is Peptic Ulcer Disease? Peptic ulcer disease is when painful sores form in the lining of the stomach, duodenum (start of the small intestine) or bowels. An ulcer can cause belly pain and, in some

More information

Gastric Ulcer / Gastritis

Gastric Ulcer / Gastritis Gastric Ulcer / Gastritis Endoscopy Department Patient information leaflet You will only be given this leaflet if you have been diagnosed with gastritis and/or a gastric ulcer. The information below outlines

More information

Data Sheet. Vesanoid. Composition. Properties and Effects. Pharmacokinetics. Tretinoin 10mg capsules. Active ingredient. Excipients.

Data Sheet. Vesanoid. Composition. Properties and Effects. Pharmacokinetics. Tretinoin 10mg capsules. Active ingredient. Excipients. 12 August 2013 Data Sheet Vesanoid Tretinoin 10mg capsules Differentiation inducing agent Composition Active ingredient All-trans retinoic acid (tretinoin). Capsules 10 mg. Excipients Capsule contents:

More information

Active ingredients: Metoclopramide Hydrochloride mg Equivalent to metoclopramide hydrochloride anhydrous mg

Active ingredients: Metoclopramide Hydrochloride mg Equivalent to metoclopramide hydrochloride anhydrous mg Name Primperan 10 mg / 2 ml Metoclopramide hydrochloride anhydrous Solution for I.M. or I.V. injection (Ampoules) Composition Each 2 ml ampoule contains: Active ingredients: Metoclopramide Hydrochloride.

More information

Summary of Product Characteristics

Summary of Product Characteristics 1 NAME OF THE MEDICINAL PRODUCT Calvepen 666 mg Tablets. Summary of Product Characteristics 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 666 mg of Phenoxymethylpenicillin Calcium equivalent

More information